-
1
-
-
0036401554
-
Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience
-
Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 2002, 16:695-714.
-
(2002)
CNS Drugs
, vol.16
, pp. 695-714
-
-
Perucca, E.1
-
2
-
-
33845653674
-
Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003
-
Koenig S.A., Buesing D., Longin E., Oehring R., Haussermann P., Kluger G., et al. Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003. Epilepsia 2006, 47:2027-2031.
-
(2006)
Epilepsia
, vol.47
, pp. 2027-2031
-
-
Koenig, S.A.1
Buesing, D.2
Longin, E.3
Oehring, R.4
Haussermann, P.5
Kluger, G.6
-
3
-
-
0020443332
-
Decreased serum carnitine in valproate induced Reye syndrome
-
Bohles H., Richter K., Wagner-Thiessen E., Schafer H. Decreased serum carnitine in valproate induced Reye syndrome. Eur J Pediatr 1982, 139:185-186.
-
(1982)
Eur J Pediatr
, vol.139
, pp. 185-186
-
-
Bohles, H.1
Richter, K.2
Wagner-Thiessen, E.3
Schafer, H.4
-
4
-
-
0022898515
-
Carnitine status in Reye and Reye-like syndromes
-
Matsuda I., Ohtani Y. Carnitine status in Reye and Reye-like syndromes. Pediatr Neurol 1986, 2:90-94.
-
(1986)
Pediatr Neurol
, vol.2
, pp. 90-94
-
-
Matsuda, I.1
Ohtani, Y.2
-
5
-
-
0029075379
-
Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity
-
Krahenbuhl S., Mang G., Kupferschmidt H., Meier P.J., Krause M. Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity. Gut 1995, 37:140-143.
-
(1995)
Gut
, vol.37
, pp. 140-143
-
-
Krahenbuhl, S.1
Mang, G.2
Kupferschmidt, H.3
Meier, P.J.4
Krause, M.5
-
6
-
-
0031770664
-
L-carnitine supplementation in childhood epilepsy: current perspectives
-
De Vivo D.C., Bohan T.P., Coulter D.L., Dreifuss F.E., Greenwood R.S., Nordli D.R., et al. l-carnitine supplementation in childhood epilepsy: current perspectives. Epilepsia 1998, 39:1216-1225.
-
(1998)
Epilepsia
, vol.39
, pp. 1216-1225
-
-
De Vivo, D.C.1
Bohan, T.P.2
Coulter, D.L.3
Dreifuss, F.E.4
Greenwood, R.S.5
Nordli, D.R.6
-
7
-
-
0035933079
-
Effect of l-carnitine treatment for valproate-induced hepatotoxicity
-
Bohan T.P., Helton E., McDonald I., Konig S., Gazitt S., Sugimoto T., et al. Effect of l-carnitine treatment for valproate-induced hepatotoxicity. Neurology 2001, 56:1405-1409.
-
(2001)
Neurology
, vol.56
, pp. 1405-1409
-
-
Bohan, T.P.1
Helton, E.2
McDonald, I.3
Konig, S.4
Gazitt, S.5
Sugimoto, T.6
-
8
-
-
0019941501
-
Carnitine deficiency and hyperammonemia associated with valproic acid therapy
-
Ohtani Y., Endo F., Matsuda I. Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr 1982, 101:782-785.
-
(1982)
J Pediatr
, vol.101
, pp. 782-785
-
-
Ohtani, Y.1
Endo, F.2
Matsuda, I.3
-
9
-
-
0022891180
-
Serum carnitine during valproic acid therapy
-
Laub M.C., Paetzke-Brunner I., Jaeger G. Serum carnitine during valproic acid therapy. Epilepsia 1986, 27:559-562.
-
(1986)
Epilepsia
, vol.27
, pp. 559-562
-
-
Laub, M.C.1
Paetzke-Brunner, I.2
Jaeger, G.3
-
11
-
-
0033017055
-
Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs
-
Verrotti A., Greco R., Morgese G., Chiarelli F. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs. Int J Clin Lab Res 1999, 29:36-40.
-
(1999)
Int J Clin Lab Res
, vol.29
, pp. 36-40
-
-
Verrotti, A.1
Greco, R.2
Morgese, G.3
Chiarelli, F.4
-
12
-
-
0026027090
-
Carnitine, valproate, and toxicity
-
Coulter D.L. Carnitine, valproate, and toxicity. J Child Neurol 1991, 6:7-14.
-
(1991)
J Child Neurol
, vol.6
, pp. 7-14
-
-
Coulter, D.L.1
-
13
-
-
0026046413
-
The effect of valproic acid on plasma carnitine levels
-
Opala G., Winter S., Vance C., Vance H., Hutchison H.T., Linn L.S. The effect of valproic acid on plasma carnitine levels. Am J Dis Child 1991, 145:999-1001.
-
(1991)
Am J Dis Child
, vol.145
, pp. 999-1001
-
-
Opala, G.1
Winter, S.2
Vance, C.3
Vance, H.4
Hutchison, H.T.5
Linn, L.S.6
-
14
-
-
0030575912
-
Inhibition of carnitine biosynthesis by valproic acid in rats-the biochemical mechanism of inhibition
-
Farkas V., Bock I., Cseko J., Sandor A. Inhibition of carnitine biosynthesis by valproic acid in rats-the biochemical mechanism of inhibition. Biochem Pharmacol 1996, 52:1429-1433.
-
(1996)
Biochem Pharmacol
, vol.52
, pp. 1429-1433
-
-
Farkas, V.1
Bock, I.2
Cseko, J.3
Sandor, A.4
-
15
-
-
0026072181
-
Alteration of renal carnitine metabolism by anticonvulsant treatment
-
Camina M.F., Rozas I., Castro-Gago M., Paz J.M., Alonso C., Rodriguez-Segade S. Alteration of renal carnitine metabolism by anticonvulsant treatment. Neurology 1991, 41:1444-1448.
-
(1991)
Neurology
, vol.41
, pp. 1444-1448
-
-
Camina, M.F.1
Rozas, I.2
Castro-Gago, M.3
Paz, J.M.4
Alonso, C.5
Rodriguez-Segade, S.6
-
16
-
-
27144539588
-
Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?
-
Lheureux P.E., Penaloza A., Zahir S., Gris M. Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?. Crit Care 2005, 9:431-440.
-
(2005)
Crit Care
, vol.9
, pp. 431-440
-
-
Lheureux, P.E.1
Penaloza, A.2
Zahir, S.3
Gris, M.4
-
17
-
-
33846235102
-
Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS
-
Werner T., Treiss I., Kohlmueller D., Mehlem P., Teich M., Longin E., et al. Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS. Epilepsia 2007, 48:72-76.
-
(2007)
Epilepsia
, vol.48
, pp. 72-76
-
-
Werner, T.1
Treiss, I.2
Kohlmueller, D.3
Mehlem, P.4
Teich, M.5
Longin, E.6
-
18
-
-
0035717641
-
Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS/MS
-
Silva M.F., Selhorst J., Overmars H., van Gennip A.H., Maya M., Wanders R.J., et al. Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS/MS. Clin Biochem 2001, 34:635-638.
-
(2001)
Clin Biochem
, vol.34
, pp. 635-638
-
-
Silva, M.F.1
Selhorst, J.2
Overmars, H.3
van Gennip, A.H.4
Maya, M.5
Wanders, R.J.6
-
19
-
-
33847391557
-
Simultaneous quantification of acylcarnitine isomers containing dicarboxylic acylcarnitines in human serum and urine by high-performance liquid chromatography/electrospray ionization-tandem mass spectrometry
-
Maeda Y., Ito T., Suzuki A., Kurono Y., Ueta A., Yokoi K., et al. Simultaneous quantification of acylcarnitine isomers containing dicarboxylic acylcarnitines in human serum and urine by high-performance liquid chromatography/electrospray ionization-tandem mass spectrometry. Rapid Commun Mass Spectrom 2007, 21:799-806.
-
(2007)
Rapid Commun Mass Spectrom
, vol.21
, pp. 799-806
-
-
Maeda, Y.1
Ito, T.2
Suzuki, A.3
Kurono, Y.4
Ueta, A.5
Yokoi, K.6
-
20
-
-
47249124537
-
Determination of 3-hydroxyisovalerylcarnitine and other acylcarnitine levels using liquid chromatography-tandem mass spectrometry in serum and urine of a patient with multiple carboxylase deficiency
-
Maeda Y., Ito T., Ohmi H., Yokoi K., Nakajima Y., Ueta A., et al. Determination of 3-hydroxyisovalerylcarnitine and other acylcarnitine levels using liquid chromatography-tandem mass spectrometry in serum and urine of a patient with multiple carboxylase deficiency. J Chromatogr B Analyt Technol Biomed Life Sci 2008, 870:154-159.
-
(2008)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.870
, pp. 154-159
-
-
Maeda, Y.1
Ito, T.2
Ohmi, H.3
Yokoi, K.4
Nakajima, Y.5
Ueta, A.6
-
21
-
-
84886640030
-
Valproylcarnitine: a novel drug metabolite identified by fast atom bombardment and thermospray liquid chromatography-mass spectrometry
-
Millington D.S., Bohan T.P., Roe C.R., Yergey A.L., Liberato D.J. Valproylcarnitine: a novel drug metabolite identified by fast atom bombardment and thermospray liquid chromatography-mass spectrometry. Clin Chim Acta 1985, 145:69-76.
-
(1985)
Clin Chim Acta
, vol.145
, pp. 69-76
-
-
Millington, D.S.1
Bohan, T.P.2
Roe, C.R.3
Yergey, A.L.4
Liberato, D.J.5
-
22
-
-
0028896016
-
Determination of urinary valproylcarnitine by gas chromatography-mass spectrometry with selected-ion monitoring
-
Muro H., Tatsuhara T., Sugimoto T., Woo M., Nishida N., Murakami K., et al. Determination of urinary valproylcarnitine by gas chromatography-mass spectrometry with selected-ion monitoring. J Chromatogr B Biomed Appl 1995, 663:83-89.
-
(1995)
J Chromatogr B Biomed Appl
, vol.663
, pp. 83-89
-
-
Muro, H.1
Tatsuhara, T.2
Sugimoto, T.3
Woo, M.4
Nishida, N.5
Murakami, K.6
-
24
-
-
43149094182
-
Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review
-
Silva M.F., Aires C.C., Luis P.B., Ruiter J.P., IJlst L., Duran M., et al. Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review. J Inherit Metab Dis. 2008, 31:205-216.
-
(2008)
J Inherit Metab Dis.
, vol.31
, pp. 205-216
-
-
Silva, M.F.1
Aires, C.C.2
Luis, P.B.3
Ruiter, J.P.4
Ijlst, L.5
Duran, M.6
-
25
-
-
0032063035
-
Valproate therapy does not deplete carnitine levels in otherwise healthy children
-
Hirose S., Mitsudome A., Yasumoto S., Ogawa A., Muta Y., Tomoda Y. Valproate therapy does not deplete carnitine levels in otherwise healthy children. Pediatrics (in eng) 1998, 101:E9.
-
(1998)
Pediatrics (in eng)
, vol.101
-
-
Hirose, S.1
Mitsudome, A.2
Yasumoto, S.3
Ogawa, A.4
Muta, Y.5
Tomoda, Y.6
-
26
-
-
0035964970
-
Differential effect of valproate and its Delta2- and Delta4-unsaturated metabolites, on the beta-oxidation rate of long-chain and medium-chain fatty acids
-
Silva M.F., Ruiter J.P., IJlst L., Jakobs C., Duran M., de Almeida I.T., et al. Differential effect of valproate and its Delta2- and Delta4-unsaturated metabolites, on the beta-oxidation rate of long-chain and medium-chain fatty acids. Chem Biol Interact 2001, 137:203-212.
-
(2001)
Chem Biol Interact
, vol.137
, pp. 203-212
-
-
Silva, M.F.1
Ruiter, J.P.2
Ijlst, L.3
Jakobs, C.4
Duran, M.5
de Almeida, I.T.6
-
27
-
-
0034854212
-
Valproate induces in vitro accumulation of long-chain fatty acylcarnitines
-
Silva M.F., Jakobs C., Duran M., de Almeida I.T., Wanders R.J. Valproate induces in vitro accumulation of long-chain fatty acylcarnitines. Mol Genet Metab 2001, 73:358-361.
-
(2001)
Mol Genet Metab
, vol.73
, pp. 358-361
-
-
Silva, M.F.1
Jakobs, C.2
Duran, M.3
de Almeida, I.T.4
Wanders, R.J.5
-
28
-
-
23044515774
-
Acute valproate poisoning: pharmacokinetics, alteration in fatty acid metabolism, and changes during therapy
-
Eyer F., Felgenhauer N., Gempel K., Steimer W., Gerbitz K.D., Zilker T. Acute valproate poisoning: pharmacokinetics, alteration in fatty acid metabolism, and changes during therapy. J Clin Psychopharmacol 2005, 25:376-380.
-
(2005)
J Clin Psychopharmacol
, vol.25
, pp. 376-380
-
-
Eyer, F.1
Felgenhauer, N.2
Gempel, K.3
Steimer, W.4
Gerbitz, K.D.5
Zilker, T.6
|